FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40142911000001106: Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2047371000001118 Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2047381000001116 Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has VMP Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Herzuma) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Zercepac) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Kanjinti) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Trazimera) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Herceptin) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start